Back to resultsTracking Optical Coherence Tomography
Primary Purpose
Macular Degeneration, Glaucoma, Diabetic Retinopathy
Status
Completed
Phase
Locations
United States
Study Type
Observational
Intervention
Sponsored by
About this trial
This is an observational trial for Macular Degeneration focused on measuring maculopathy
Eligibility Criteria
Inclusion Criteria: Healthy individuals (this includes women of child-bearing potential) who are familiar with vision experiments and ophthalmic equipment, all over 18 years. Subjects will have a retinal screening if they are over 50 years old or have a known risk factor for eye disease, such as family history of age related macular degeneration or cardiovascular disease. Patients with retinal and choroidal disease: age related maculopathy or age related macular degeneration, diabetic retinopathy, glaucoma. Exclusion Criteria: Over 85 years old
Sites / Locations
- University of Pittsburgh
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00343603
First Posted
June 19, 2006
Last Updated
October 24, 2016
Sponsor
University of Pittsburgh
Collaborators
National Eye Institute (NEI)
1. Study Identification
Unique Protocol Identification Number
NCT00343603
Brief Title
Tracking Optical Coherence Tomography
Official Title
Tracking Optical Coherence Tomography
Study Type
Observational
2. Study Status
Record Verification Date
July 2011
Overall Recruitment Status
Completed
Study Start Date
October 2004 (undefined)
Primary Completion Date
December 2010 (Actual)
Study Completion Date
January 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Pittsburgh
Collaborators
National Eye Institute (NEI)
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this research study is to evaluate an investigational system that may allow doctors to show images of the different parts inside the eye that show greater detail than current equipment can produce.
Detailed Description
The purpose of this research study is to evaluate an investigational system that may allow doctors to make images of the parts inside the eye that show greater detail than current equipment can produce.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Macular Degeneration, Glaucoma, Diabetic Retinopathy, Choroidal Disease
Keywords
maculopathy
7. Study Design
Enrollment
100 (Actual)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy individuals (this includes women of child-bearing potential) who are familiar with vision experiments and ophthalmic equipment, all over 18 years.
Subjects will have a retinal screening if they are over 50 years old or have a known risk factor for eye disease, such as family history of age related macular degeneration or cardiovascular disease.
Patients with retinal and choroidal disease: age related maculopathy or age related macular degeneration, diabetic retinopathy, glaucoma.
Exclusion Criteria:
Over 85 years old
Study Population Description
Subject can range between 18 to 85 years old. They can be healthy or diseased. Recruiting males and females.
Sampling Method
Non-Probability Sample
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gadi Wollstein, MD
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Tracking Optical Coherence Tomography
We'll reach out to this number within 24 hrs